Diarrhoea Diarrhoea is another potential side effect, as GLP-1 medications can alter the digestive process
Major trials conducted in patients with MASLD have reported prevalence rates of 4246%, 1938%, and 1519% for these symptoms, respectively
If there are gimmicky marketing claims but little transparency then its a no from me
The options may be chosen on the product page FAQs What are the most common GLP-1 side effects
The Ripple Effect of Weight Loss PCOS and obesity or being overweight have a bidirectional relationship: PCOS increases the risk of being overweight or obese, while the latter can make other PCOS symptoms worse
Similarly, an analysis utilizing the UK Clinical Practice Research Datalink (CPRD) revealed that GLP-1 RAs were linked to an increased incidence of intestinal obstruction requiring hospitalization, compared to sodium-glucose cotransporter-2 (SGLT-2) inhibitors (1.9 vs